The Role of EOS in Regulatory T-cell Biology.
The Role of EOS in Regulatory T-cell Biology.
批准号:
8683077
负责人:
DREW M. PARDOLL
金额:
$40.59万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2015-06-30
关键词:
AblationAffectBindingC-Terminal Binding Protein 1Cell LineageCellsCellular biologyComplexCuesDataDevelopmentDrug usageEquilibriumEragrostisFamilyGene ActivationGene SilencingGenesHomeostasisImmuneImmune responseImmunityIn VitroInterferonsInterleukin-17Interleukin-2Knock-outMaintenanceMediatingMediator of activation proteinMetabolicMethylationMicroRNAsMolecularNADHOxidation-ReductionPathway interactionsPhysiologicalProcessRNA InterferenceRegulationRegulatory T-LymphocyteRoleSmall Interfering RNAStimulusSystemT-LymphocyteTestingZinc Fingersbalance testingcytokineflexibilitygene repressionhistone modificationimmune self tolerancein vivomutantpromoterresponsetranscription factor
中文摘要
描述(由申请人提供):自然产生和适应性发育的Foxp3+CD4+调节性T细胞(Treg)通过抑制异常或过度的免疫反应,对维持免疫自我耐受和免疫动态平衡至关重要。Treg特异性地表达转录因子Foxp3,它介导CTLA-4和GITR等基因的协同激活,以及通常由效应T细胞(TEF)表达的细胞因子如IL-2、IL-17和干扰素-β的沉默。特雷格和特雷夫之间的功能界限并不是绝对的。事实上,Treg和Tef之间的灵活性可能是生理和病理生理免疫反应的重要组成部分。要了解这种功能互换,需要了解免疫效应基因在Treg中通常是如何沉默的。尽管对Foxp3依赖的基因激活机制的研究取得了进展,但Foxp3依赖的基因抑制的分子机制尚未阐明。最近,我们发现Eos是Ikaros家族的一个锌指转录因子,在Treg中是Foxp3依赖的基因沉默的关键介质。Eos与Foxp3直接相互作用,在不影响Foxp3激活基因表达的情况下,是基因沉默所必需的。我们进一步证明了Eos及其辅阻遏子C端结合蛋白1(CtBP1)是组蛋白修饰所必需的,最终启动子甲基化参与了Treg基因的选择性沉默。在Treg中Eos被敲除后,它们在体外和体内抑制免疫反应的能力被剥夺。我们推测,Eos-CtBP-1基因沉默在Treg中是一个高度调控的过程,影响其作为免疫抑制者和免疫效应者的功能。在目前的方案中,我们将进一步探讨代谢和microRNA依赖的调节Treg中Eos-CtBP1基因沉默的机制,以及在体内阻断这一途径对Treg发育、动态平衡和适应性免疫反应调节的影响。具体地说,我们将1)阐明影响NADH/NAD平衡的代谢刺激在Eos通过CtBP1复合体介导的基因沉默中的作用;2)研究microRNAs对Treg细胞中Eos表达的调节;3)研究Eos缺失对Treg细胞的动态平衡、分化和适应性Treg细胞发育的影响。
英文摘要
DESCRIPTION (provided by applicant): Naturally occurring as well as adaptively developed Foxp3+CD4+ regulatory T cells (Treg) are central to the maintenance of immunological self-tolerance and immune homeostasis by suppressing aberrant or excessive immune responses. Treg specifically express the transcription factor Foxp3, which mediates the coordinate activation of genes such as CTLA-4 and GITR along with silencing of cytokines such as interleukin-2, IL-17 and interferon-?, that are normally expressed by effector T cells (Teff). The functional boundary between Treg and the Teff they are meant to suppress is not absolute. In fact, the flexibility between Treg and Teff may be an important component to both physiologic and pathophysiologic immune responses. Understanding this functional interchange requires an understanding of how immune effector genes are normally silenced in Treg. Despite progress in understanding mechanisms of Foxp3-dependent gene activation, the molecular mechanism of Foxp3-dependent gene repression has not been elucidated. Recently, we identified Eos, a zinc-finger transcription factor of the Ikaros family, as a critical mediator of Foxp3-dependent gene silencing in Treg. Eos interacts directly with Foxp3 and is necessary for gene silencing without affecting expression of Foxp3 activated genes. We further demonstrated that Eos and its corepressor C-terminal binding protein 1 (CtBP1) are necessary for histone modifications and ultimately promoter methylation involved in selective gene silencing in Treg. Knockdown of Eos in Treg abrogates their ability to suppress immune responses in vitro and in vivo. We hypothesize that Eos-CtBP-1 gene silencing is a highly regulated process in Treg that impacts on their function as suppressors vs. effectors of immunity. In the current proposal, we will further explore metabolic and microRNA dependent mechanisms of regulation of Eos-CtBP1 gene silencing in Treg as well as the in vivo consequences of ablation of this pathway for Treg development, homeostasis and modulation of adaptive immune responses. Specifically, we will 1) Elucidate the role of metabolic stimuli that affect NADH/NAD balance in Eos mediated gene silencing via the CtBP1 complex, 2) Study the regulation of Eos expression in Treg cells by microRNAs and 3) Study the consequences of Eos deletion to Treg cell homeostasis, differentiation and adaptive Treg cell development.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1152/ajpcell.00204.2015
发表时间:
2015-11
期刊:
American journal of physiology. Cell physiology
影响因子:
--
作者:
[Jin-Hui Tao;J. Barbi;F. Pan]
通讯作者:
Jin-Hui Tao;J. Barbi;F. Pan
DOI:
10.1111/imr.12172
发表时间:
2014-05
期刊:
Immunological reviews
影响因子:
8.7
作者:
[Barbi J, Pardoll D, Pan F]
通讯作者:
Pan F
DOI:
10.1111/imr.12312
发表时间:
2015-07
期刊:
Immunological reviews
影响因子:
8.7
作者:
[Barbi J, Pardoll DM, Pan F]
通讯作者:
Pan F
DOI:
10.1007/s00109-014-1156-z
发表时间:
2014-06
期刊:
JOURNAL OF MOLECULAR MEDICINE-JMM
影响因子:
4.7
作者:
[Pan, Fan, Barbi, Joseph]
通讯作者:
Barbi, Joseph
DOI:
10.1111/imr.12029
发表时间:
2013-03
期刊:
Immunological reviews
影响因子:
8.7
作者:
[Barbi J, Pardoll D, Pan F]
通讯作者:
Pan F
共 8 条
Role of YAP in Treg Function and YAP Targeting for Cancer Immunotherapy
-
批准号:10547779
-
项目类别:
-
资助金额:$36.71万
-
财政年份:2018
-
负责人:DREW M. PARDOLL
-
依托单位:
Role of YAP in Treg Function and YAP Targeting for Cancer Immunotherapy
-
批准号:10330418
-
项目类别:
-
资助金额:$36.71万
-
财政年份:2018
-
负责人:DREW M. PARDOLL
-
依托单位:
E3 ligase mediated control of Foxp3 expression and immune suppression-mechanisms and potential as immunotherapeutic target
-
批准号:10331033
-
项目类别:
-
资助金额:$37.91万
-
财政年份:2018
-
负责人:DREW M. PARDOLL
-
依托单位:
The Role of EOS in Regulatory T-cell Biology.
-
批准号:8490291
-
项目类别:
-
资助金额:$38.15万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
Mechanisms of TH17 Inflammation-Induced Colon Carcihogenesis
-
批准号:8657874
-
项目类别:
-
资助金额:$32.02万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
Mechanisms of TH17 Inflammation-Induced Colon Carcihogenesis
-
批准号:8105255
-
项目类别:
-
资助金额:$33.01万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
Enterotoxigenic Bacteroides fragilis: A bacterial promoter of colon oncogenesis
-
批准号:8707985
-
项目类别:
-
资助金额:$54.86万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
PD-1/PD-L1 modulation in cancer therapy
-
批准号:10355495
-
项目类别:
-
资助金额:$58.81万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
PD-1/PD-L1 modulation in cancer therapy
-
批准号:9188057
-
项目类别:
-
资助金额:$48.83万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
Enterotoxigenic Bacteroides fragilis: A bacterial promoter of colon oncogenesis
-
批准号:8137121
-
项目类别:
-
资助金额:$52.15万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
The Role of EOS in Regulatory T-cell Biology.
-
批准号:8289608
-
项目类别:
-
资助金额:$40.59万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
Enterotoxigenic Bacteroides fragilis: A bacterial promoter of colon oncogenesis
-
批准号:8303450
-
项目类别:
-
资助金额:$57.03万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
Mechanisms of TH17 Inflammation-Induced Colon Carcihogenesis
-
批准号:8455705
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
The Role of EOS in Regulatory T-cell Biology.
-
批准号:7947180
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
Mechanisms of TH17 Inflammation-Induced Colon Carcihogenesis
-
批准号:8247110
-
项目类别:
-
资助金额:$33.01万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
Enterotoxigenic Bacteroides fragilis: A bacterial promoter of colon oncogenesis
-
批准号:8508195
-
项目类别:
-
资助金额:$48.7万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
The Role of EOS in Regulatory T-cell Biology.
-
批准号:8100380
-
项目类别:
-
资助金额:$40.59万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
PD-1/PD-L1 modulation in cancer therapy
-
批准号:10588130
-
项目类别:
-
资助金额:$60.01万
-
财政年份:2010
-
负责人:DREW M. PARDOLL
-
依托单位:
A phase I trial to assess the immunogenicity, safety, tolerability and efficacy o
-
批准号:7727553
-
项目类别:
-
资助金额:$21.3万
-
财政年份:2009
-
负责人:DREW M. PARDOLL
-
依托单位:
Developmental Research Program
-
批准号:7727562
-
项目类别:
-
资助金额:$10.6万
-
财政年份:2009
-
负责人:DREW M. PARDOLL
-
依托单位:
海外基金